Veradermics (MANE), a hair loss therapy developer, files for a U.S. IPO, targeting up to $534M valuation and $182M in net proceeds. Read more here.

Something’s been amiss when I wash my hair. Instead of the odd few strands escaping — totally normal, by the way — my hands ...

A centuries-old medicinal root is gaining renewed scientific attention for its ability to target multiple biological processes involved in hair loss. Androgenetic alopecia (AGA) is the most common ...

There's nothing worse than discovering your favorite health and beauty products are discontinued. Unfortunately, it is ...

A popular over-the-counter supplement that patients with cancer are prescribed or buy on their own to improve hair and nail ...

All dosing regimens of topical GT20029 among men with androgenetic alopecia had significant improvements in growth of target area non-vellus hair count at 12 weeks of treatment compared with placebo.

Hair loss and thinning can be frustrating, emotional, and, unfortunately, incredibly common. Whether you're spotting extra strands in the shower or noticing your ponytail feels thinner than it used to ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

Finasteride can be prescribed off-label to treat female pattern hair loss (FPHL), but it is not FDA-approved for women. Side effects in women range from mild (like headaches or acne) to serious (such ...